959631-30-2Relevant academic research and scientific papers
HETEROCYCLIC FXR MODULATORS
-
Paragraph 0118; 0120, (2018/05/16)
The present technology is directed to compounds of formula (I), compositions, and methods related to modulation of FXR. In particular, the present compounds and compositions may be used to treat FXR-mediated disorders and conditions, including, e.g., liver disease, hyperlipidemia, hypercholesteremia, obesity, metabolic syndrome, cardiovascular disease, gastrointestinal disease, and atherosclerosis, and renal disease.
COMPOUNDS AND METHODS FOR MODULATING FXR
-
Page/Page column 22, (2009/03/07)
Compounds of formula (I): formula (I) wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and diseases related to dyslipidemia.
FXR AGONISTS
-
Page/Page column 24-25, (2008/06/13)
Compounds of formula wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and related diseases.
